Risk of cancer in patients with biopsy-proven giant cell arteritis

被引：21
|
作者：
Hill, Catherine L. [1 ]
Cole, Antonia [1 ]
Rischmueller, Maureen [1 ]
Dodd, Thomas [2 ]
Coleman, Mark [3 ]
Tucker, Graeme [4 ]
Roberts-Thomson, Peter [5 ]
机构：
[1] Queen Elizabeth Hosp, Rheumatol Unit, Woodville, SA 5011, Australia
[2] SA Pathol, Dept Tissue Pathol, Adelaide, SA, Australia
[3] Flinders Med Ctr, Dept Anat Pathol, Bedford Pk, SA, Australia
[4] Dept Hlth, Hlth Stat Unit, Adelaide, SA, Australia
[5] Flinders Med Ctr, Dept Allergy Immunol & Arthritis, Bedford, SA, Australia
来源：
RHEUMATOLOGY | 2010年 / 49卷 / 04期
关键词：
Giant cell arteritis; Malignancy; Epidemiology; Population;
D O I：
10.1093/rheumatology/kep409
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective. Results of previous studies investigating the association between GCA and malignancy are conflicting. We performed a study of the risk of cancer in patients with biopsy-proven GCA. Methods. Patients with biopsy-proven GCA were identified from pathology reports of temporal artery biopsies from the major pathology laboratories in South Australia (SA). All subjects with biopsy-proven GCA were linked to the SA Cancer Registry to identify cases of cancer until 31 December 2006. Standardized incidence ratios (SIRs) for cancer were determined using the age-and gender-specific rates for SA. Results. There were 226 cases of biopsy-proven GCA (163 females and 63 males). Thirty-one cases were diagnosed with cancer, following the diagnosis of biopsy-proven GCA. There was no increased risk of cancer among those with biopsy-proven GCA, following the diagnosis of GCA compared with the general population (SIR 1.2; 95% Cl 0.8, 1.6). Conclusion. This cohort study did not demonstrate any increased risk for malignancy in subjects with biopsy-proven GCA.
引用
收藏
页码：756 / 759
页数：4
相关论文
共 50 条
  • [41] Spinal Cord Presentation of Biopsy-Proven PET-Positive Giant Cell Arteritis
    Swart, Grace
    Balgobind, Sapna
    Chan, Charles
    Fulham, Michael
    Riminton, Sean
    Mitchell, Emma
    Reddel, Stephen William
    NEUROLOGY, 2022, 98 (23) : 982 - 983
  • [42] Incidence, Prevalence and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy.
    Catanoso, Mariagrazia
    Macchioni, Pierluigi
    Boiardi, Luigi
    Muratore, Francesco
    Restuccia, Giovanna
    Cavazza, Alberto
    Luberto, Ferdinando
    Salvarani, Carlo
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S344 - S344
  • [43] A Nonsynonymous Functional Variant of the ITGAM Gene Is Not Involved in Biopsy-proven Giant Cell Arteritis
    David Carmona, F.
    Serrano, Aurora
    Rodriguez-Rodriguez, Luis
    Castaneda, Santos
    Miranda-Flloy, Jose A.
    Morado, Inmaculada C.
    Narvaez, Javier
    Solans, Roser
    Sopena, Bernardo
    Mari-Alfonso, Begona
    Unzurrunzaga, Ainhoa
    Ortego-Centeno, Norberto
    Blanco, Ricardo
    de Miguel, Eugenio
    Hidalgo-Conde, Ana
    Martin, Javier
    Gonzalez-Gay, Miguel A.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (12) : 2598 - 2601
  • [44] Endothelial nitric oxide synthase haplotype associations in biopsy-proven giant cell arteritis
    Amoli, MM
    Garcia-Porrua, C
    Llorca, J
    Ollier, WER
    Gonzalez-Gay, MA
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (09) : 2019 - 2022
  • [45] Thrombocytosis in patients with biopsy proven giant cell arteritis.
    Foroozan, R
    Savino, PJ
    Sergott, RC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S625 - S625
  • [46] Fluorodeoxyglucose-positron emission tomography disease activity assessment in patients with biopsy-proven giant cell arteritis
    Simo, M.
    Navales, I.
    Mestres, J.
    Martinez, F.
    Solans, R.
    Salcedo, M.
    Barios, M.
    Boronat, M.
    Castell, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S479 - S479
  • [47] DEVELOPMENT OF AORTIC ANEURYSM/DILATATION IN A PROSPECTIVE COHORT OF PATIENTS WITH BIOPSY-PROVEN GIANT-CELL ARTERITIS: EARLY IDENTIFICATION OF PATIENTS AT RISK.
    Hernandez, J. Marco
    Garcia-Martinez, A.
    Prieto-Gonzalez, S.
    Suso, A.
    Espigol-Frigole, G.
    Arguis, P.
    Gilabert, R.
    Alba, M.
    Hernandez-Rodriguez, J.
    Cid, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 378 - 378
  • [48] Biopsy-proven giant cell arteritis patients with coronary artery disease have increased risk of aortic aneurysmal disease and arterial thrombosis
    Gonzalez-Gay, M. A.
    Garcia-Porrua, C.
    Gonzalez-Juanatey, C.
    Miranda-Filloy, J. A.
    Blanco, R.
    Llorca, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (01) : S94 - S94
  • [49] Association of CD24 gene Polymorphisms with susceptibility to biopsy-proven giant cell arteritis
    Rueda, Blanca
    Miranda-Filloy, Jose A.
    Martin, Javier
    Gonzalez-Gay, Miguel A.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (05) : 850 - 854
  • [50] Comparison of Clinical Manifestations in Different Histological Subsets of Biopsy-Proven Giant Cell Arteritis.
    Boiardi, Luigi
    Muratore, Francesco
    Cavazza, Alberto
    Restuccia, Giovanna
    Macchioni, Pierluigi
    Germano, Giuseppe
    Pipitone, Nicolo
    Bajocchi, Gianluigi
    Salvarani, Carlo
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S346 - S347
12345